Hyperion Defi (HYPD) Retained Earnings (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Retained Earnings of -$231.8 million for Q1 2026, down 16.6% year-over-year from -$277.9 million in Q1 2025, and up 3.67% quarter-over-quarter from -$240.6 million in Q4 2025.
Hyperion Defi (HYPD) Retained Earnings (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Retained Earnings for 11 consecutive years, with -$231.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Retained Earnings fell 16.6% year-over-year to -$231.8 million; the TTM figure through Mar 2026 stood at -$231.8 million (down 16.6% YoY), while the FY2025 annual figure was -$240.6 million, down 232.06% from the prior year.
- Retained Earnings climbed to -$231.8 million in Q1 2026 per HYPD's latest filing, from -$240.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $271.6 million in Q3 2025 and bottomed at -$240.6 million in Q4 2025.
- Historically, Retained Earnings has averaged $17.9 million across 5 years, with a median of $128.4 million in 2022.
- Annual changes were most pronounced in 2022 — Retained Earnings soared 246.52% — and 2025, when it plunged 232.06%.
- Hyperion Defi's Retained Earnings stood at $135.5 million in 2022, then gained by 14.05% to $154.5 million in 2023, then grew by 17.94% to $182.2 million in 2024, then slumped by 232.06% to -$240.6 million in 2025, then climbed by 3.67% to -$231.8 million in 2026.
- Business Quant data shows HYPD's Retained Earnings at -$231.8 million in Q1 2026, -$240.6 million in Q4 2025, and $271.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -6.33 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.57 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 4.38 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 20.91 Bn |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 302.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 302.77 Mn |
| Mar 31, 2026 | -231.78 Mn |
| Dec 31, 2025 | -240.62 Mn |
| Sep 30, 2025 | 271.61 Mn |
| Jun 30, 2025 | 244.84 Mn |
| Mar 31, 2025 | -198.79 Mn |
| Dec 31, 2024 | 182.21 Mn |
| Sep 30, 2024 | 179.07 Mn |
| Jun 30, 2024 | -167.47 Mn |
| Mar 31, 2024 | 158.23 Mn |
| Dec 31, 2023 | 154.49 Mn |
| Sep 30, 2023 | 153.30 Mn |
| Jun 30, 2023 | -130.19 Mn |
| Mar 31, 2023 | -123.97 Mn |
| Dec 31, 2022 | 135.46 Mn |
| Sep 30, 2022 | -112.10 Mn |
| Jun 30, 2022 | 128.41 Mn |
| Mar 31, 2022 | -97.56 Mn |
| Dec 31, 2021 | 110.68 Mn |
| Sep 30, 2021 | 97.45 Mn |